Literature DB >> 5286447

Patient survival after chemotherapy and its relationship to in vitro lymphocyte blastogenesis.

A R Cheema, E M Hersh.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1971        PMID： 5286447     DOI： 10.1002/1097-0142(1971)28:4<851::aid-cncr2820280408>3.0.co;2-e

Source DB:  PubMed          Journal:  Cancer        ISSN： 0008-543X            Impact factor:   6.860


× No keyword cloud information.
  14 in total

1.  Proceedings: The effect of immunosuppression on cancer.

Authors:  I Penn; T E Starzl
Journal:  Proc Natl Cancer Conf       Date:  1972

2.  Serial studies of immunocompetence of patients undergoing chemotherapy for acute leukemia.

Authors:  E M Hersh; J U Gutterman; G M Mavligit; K B McCredie; M A Burgess; A Matthews; E J Freireich
Journal:  J Clin Invest       Date:  1974-08       Impact factor: 14.808

3.  Quantitative dinitrochlorobenzene contact sensitization in a normal population.

Authors:  W J Catalona; P T Taylor; P B Chretien
Journal:  Clin Exp Immunol       Date:  1972-11       Impact factor: 4.330

4.  Chemotherapy, a double agent in respect of immune functions.

Authors:  G Mathé
Journal:  Cancer Chemother Pharmacol       Date:  1978       Impact factor: 3.333

5.  Effect of intravenous hyperalimentation on established delayed hypersensitivity in the cancer patient.

Authors:  E M Copeland; B V Fadyen; S J Dudrick
Journal:  Ann Surg       Date:  1976-07       Impact factor: 12.969

6.  Inhibition of lymphocyte response by prostaglandin-producing suppressor cells in patients with melanoma.

Authors:  J L Murray; G M Kollmorgen
Journal:  J Clin Immunol       Date:  1983-07       Impact factor: 8.317

7.  Tuberculin and dinitrochlorobenzene (DNCB) tests in cancer patients before and after cytostatic drug therapy.

Authors:  W Weber; H P Missmahl; B Mazloumi
Journal:  Klin Wochenschr       Date:  1978-09-15

8.  Multicenter International Society for Immunotherapy of Cancer Study of the Consensus Immunoscore for the Prediction of Survival and Response to Chemotherapy in Stage III Colon Cancer.

Authors:  Bernhard Mlecnik; Carlo Bifulco; Gabriela Bindea; Florence Marliot; Alessandro Lugli; J Jack Lee; Inti Zlobec; Tilman T Rau; Martin D Berger; Iris D Nagtegaal; Elisa Vink-Börger; Arndt Hartmann; Carol Geppert; Julie Kolwelter; Susanne Merkel; Robert Grützmann; Marc Van den Eynde; Anne Jouret-Mourin; Alex Kartheuser; Daniel Léonard; Christophe Remue; Julia Y Wang; Prashant Bavi; Michael H A Roehrl; Pamela S Ohashi; Linh T Nguyen; SeongJun Han; Heather L MacGregor; Sara Hafezi-Bakhtiari; Bradly G Wouters; Giuseppe V Masucci; Emilia K Andersson; Eva Zavadova; Michal Vocka; Jan Spacek; Lubos Petruzelka; Bohuslav Konopasek; Pavel Dundr; Helena Skalova; Kristyna Nemejcova; Gerardo Botti; Fabiana Tatangelo; Paolo Delrio; Gennaro Ciliberto; Michele Maio; Luigi Laghi; Fabio Grizzi; Tessa Fredriksen; Bénédicte Buttard; Lucie Lafontaine; Daniela Bruni; Anastasia Lanzi; Carine El Sissy; Nacilla Haicheur; Amos Kirilovsky; Anne Berger; Christine Lagorce; Christopher Paustian; Carmen Ballesteros-Merino; Jeroen Dijkstra; Carlijn van de Water; Shannon van Lent-van Vliet; Nikki Knijn; Ana-Maria Muşină; Dragos-Viorel Scripcariu; Boryana Popivanova; Mingli Xu; Tomonobu Fujita; Shoichi Hazama; Nobuaki Suzuki; Hiroaki Nagano; Kiyotaka Okuno; Toshihiko Torigoe; Noriyuki Sato; Tomohisa Furuhata; Ichiro Takemasa; Kyogo Itoh; Prabhu S Patel; Hemangini H Vora; Birva Shah; Jayendrakumar B Patel; Kruti N Rajvik; Shashank J Pandya; Shilin N Shukla; Yili Wang; Guanjun Zhang; Yutaka Kawakami; Francesco M Marincola; Paolo A Ascierto; Bernard A Fox; Franck Pagès; Jérôme Galon
Journal:  J Clin Oncol       Date:  2020-09-08       Impact factor: 44.544

9.  Value of lymphocyte reactivity induced by phytohemagglutinin in the treatment of malignant diseases.

Authors:  S Fujimoto; T Minami; B Itoh; H Ishigami; M Miyazaki
Journal:  Jpn J Surg       Date:  1977-03

10.  Thymus-derived rosette-forming cells in various human disease states: cancer, lymphoma, bacterial and viral infections, and other diseases.

Authors:  J Wybran; H H Fudenberg
Journal:  J Clin Invest       Date:  1973-05       Impact factor: 14.808
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.